EcoDrugPlus

Maltase-Glucoamylase

Ensembl ID : ENSMMSG00000001266
Gene Symbol: MGAM
1 Cross references
312 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSMMSG00000020664
Gene Symbol: MMP1
1 Cross references
352 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSMMSG00000020713
Gene Symbol: MMP12
1 Cross references
550 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSMMSG00000020775
Gene Symbol: MMP13
1 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSMMSG00000003242
Gene Symbol: MMP14
1 Cross references
269 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSMMSG00000010869
Gene Symbol: MMP2
1 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSMMSG00000020691
Gene Symbol: MMP3
1 Cross references
493 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSMMSG00000020500
Gene Symbol: MMP7
1 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSMMSG00000020627
Gene Symbol: MMP8
1 Cross references
111 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSMMSG00000003322
Gene Symbol: MMP9
1 Cross references
214 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSMMSG00000018337
Gene Symbol: MTOR
1 Cross references
214 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSMMSG00000006505
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).